| Post |
| Pre |
| LA |
|---|
| - |
| - |
| ME 1 | ME 2 | ME 3 | ME 4 | ME 5 | ME 6 | ME 7 | ME 8 | ME 9 | ME 10 | Total |
|---|---|---|---|---|---|---|---|---|---|---|
| 67 | 17 | 8 | 4 | 7 | 1 | 20 | 9 | - | - | 133 |
| - | - | 1 | - | - | - | - | 8 | - | - | 9 |
| Post |
| Pre |
| LO 1 | LO 2 | LO 3 | LO 4 | LO 5A | LO 5B | LO 6 | Total |
|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - |
| - | - | - | - | - | - | - | - |
| AME |
|---|
| 735 |
| 11 |
| Post |
| Pre |
| LOP 1 | LOP 2 | LOP 3 | LOP 4 | Total |
|---|---|---|---|---|
| - | - | - | - | - |
| - | - | - | - | - |
| central brain |
|---|
| 219 |
| 461 |

| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| AME(R) | 735 | 60.6% | -6.06 | 11 | 2.2% |
| PLP(R) | 190 | 15.7% | 0.83 | 338 | 68.4% |
| CentralBrain-unspecified | 29 | 2.4% | 2.08 | 123 | 24.9% |
| ME(R) | 133 | 11.0% | -3.89 | 9 | 1.8% |
| Optic-unspecified(R) | 125 | 10.3% | -3.27 | 13 | 2.6% |
| upstream partner | # | NT | conns aMe6a | % In | CV |
|---|---|---|---|---|---|
| aMe4 (R) | 9 | ACh | 269 | 22.6% | 0.4 |
| HBeyelet (R) | 3 | HA | 261 | 21.9% | 0.2 |
| MeVPMe12 (L) | 2 | ACh | 197 | 16.6% | 0.0 |
| OCG02c (L) | 2 | ACh | 82 | 6.9% | 0.3 |
| MeVPaMe2 (L) | 1 | Glu | 61 | 5.1% | 0.0 |
| Dm9 (R) | 5 | Glu | 54 | 4.5% | 0.8 |
| MeVCMe1 (R) | 2 | ACh | 32 | 2.7% | 0.1 |
| OCG02c (R) | 2 | ACh | 30 | 2.5% | 0.9 |
| OA-AL2i3 (R) | 2 | OA | 28 | 2.4% | 0.7 |
| MeVCMe1 (L) | 2 | ACh | 27 | 2.3% | 0.0 |
| aMe12 (R) | 2 | ACh | 22 | 1.8% | 0.5 |
| CB0670 (R) | 1 | ACh | 16 | 1.3% | 0.0 |
| Dm20 (R) | 4 | Glu | 14 | 1.2% | 0.1 |
| LoVC20 (L) | 1 | GABA | 11 | 0.9% | 0.0 |
| aMe1 (R) | 2 | GABA | 11 | 0.9% | 0.1 |
| MeVPMe3 (L) | 1 | Glu | 9 | 0.8% | 0.0 |
| aMe30 (R) | 2 | Glu | 6 | 0.5% | 0.3 |
| aMe6c (R) | 1 | Glu | 5 | 0.4% | 0.0 |
| LoVP96 (R) | 1 | Glu | 5 | 0.4% | 0.0 |
| MeVC20 (R) | 2 | Glu | 5 | 0.4% | 0.6 |
| aMe6b (R) | 1 | ACh | 4 | 0.3% | 0.0 |
| MeVP49 (R) | 1 | Glu | 4 | 0.3% | 0.0 |
| aMe5 (R) | 2 | ACh | 3 | 0.3% | 0.3 |
| l-LNv (R) | 3 | unc | 3 | 0.3% | 0.0 |
| R8y | 1 | HA | 2 | 0.2% | 0.0 |
| Dm10 (R) | 1 | GABA | 2 | 0.2% | 0.0 |
| Dm8a (R) | 1 | Glu | 2 | 0.2% | 0.0 |
| Mi10 (R) | 1 | ACh | 2 | 0.2% | 0.0 |
| aMe10 (L) | 1 | ACh | 2 | 0.2% | 0.0 |
| Tm16 (R) | 2 | ACh | 2 | 0.2% | 0.0 |
| aMe12 (L) | 2 | ACh | 2 | 0.2% | 0.0 |
| l-LNv (L) | 1 | unc | 1 | 0.1% | 0.0 |
| AN09A005 (L) | 1 | unc | 1 | 0.1% | 0.0 |
| Tm9 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| Cm7 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| MeLo7 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| Lat3 (R) | 1 | unc | 1 | 0.1% | 0.0 |
| aMe2 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| PS272 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| s-LNv (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| LPT51 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| aMe3 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| MeVP29 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| PLP246 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| LT58 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| LoVC4 (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| LoVCLo3 (L) | 1 | OA | 1 | 0.1% | 0.0 |
| LoVCLo3 (R) | 1 | OA | 1 | 0.1% | 0.0 |
| downstream partner | # | NT | conns aMe6a | % Out | CV |
|---|---|---|---|---|---|
| aMe30 (R) | 2 | Glu | 231 | 19.1% | 0.3 |
| PLP080 (R) | 1 | Glu | 175 | 14.5% | 0.0 |
| LoVP96 (R) | 1 | Glu | 135 | 11.2% | 0.0 |
| aMe1 (R) | 2 | GABA | 102 | 8.4% | 0.1 |
| DNpe021 (R) | 1 | ACh | 57 | 4.7% | 0.0 |
| AOTU054 (R) | 1 | GABA | 55 | 4.5% | 0.0 |
| SLP250 (R) | 1 | Glu | 32 | 2.6% | 0.0 |
| KCg-s1 (R) | 1 | DA | 24 | 2.0% | 0.0 |
| LoVP53 (R) | 1 | ACh | 22 | 1.8% | 0.0 |
| PLP211 (R) | 1 | unc | 20 | 1.7% | 0.0 |
| LoVP50 (R) | 3 | ACh | 19 | 1.6% | 0.7 |
| OCG02c (L) | 2 | ACh | 18 | 1.5% | 0.2 |
| MeVC20 (R) | 2 | Glu | 17 | 1.4% | 0.4 |
| LT58 (R) | 1 | Glu | 16 | 1.3% | 0.0 |
| AOTU055 (R) | 1 | GABA | 15 | 1.2% | 0.0 |
| LoVP31 (R) | 1 | ACh | 15 | 1.2% | 0.0 |
| aMe17c (R) | 2 | Glu | 14 | 1.2% | 0.7 |
| s-LNv (R) | 4 | ACh | 14 | 1.2% | 0.8 |
| MeVC21 (R) | 3 | Glu | 14 | 1.2% | 0.3 |
| aMe6b (R) | 1 | ACh | 9 | 0.7% | 0.0 |
| aMe3 (R) | 1 | Glu | 9 | 0.7% | 0.0 |
| aMe2 (R) | 2 | Glu | 9 | 0.7% | 0.8 |
| aMe17e (R) | 1 | Glu | 8 | 0.7% | 0.0 |
| MeVPMe11 (L) | 1 | Glu | 7 | 0.6% | 0.0 |
| OCG02c (R) | 2 | ACh | 7 | 0.6% | 0.1 |
| MeVP11 (R) | 6 | ACh | 7 | 0.6% | 0.3 |
| LAL047 (R) | 1 | GABA | 6 | 0.5% | 0.0 |
| PLP099 (R) | 1 | ACh | 6 | 0.5% | 0.0 |
| AVLP571 (R) | 1 | ACh | 6 | 0.5% | 0.0 |
| LoVC20 (L) | 1 | GABA | 6 | 0.5% | 0.0 |
| MeLo1 (R) | 2 | ACh | 6 | 0.5% | 0.0 |
| LoVP38 (R) | 2 | Glu | 5 | 0.4% | 0.6 |
| aMe8 (R) | 2 | unc | 5 | 0.4% | 0.6 |
| Lat2 (R) | 2 | unc | 5 | 0.4% | 0.2 |
| CL063 (R) | 1 | GABA | 4 | 0.3% | 0.0 |
| LoVP28 (R) | 1 | ACh | 4 | 0.3% | 0.0 |
| aMe5 (R) | 1 | ACh | 4 | 0.3% | 0.0 |
| Cm28 (R) | 1 | Glu | 4 | 0.3% | 0.0 |
| LoVP100 (R) | 1 | ACh | 4 | 0.3% | 0.0 |
| LoVC18 (R) | 1 | DA | 3 | 0.2% | 0.0 |
| Lat1 (R) | 1 | unc | 3 | 0.2% | 0.0 |
| LC37 (R) | 1 | Glu | 3 | 0.2% | 0.0 |
| MeVP50 (R) | 1 | ACh | 3 | 0.2% | 0.0 |
| aMe20 (R) | 1 | ACh | 3 | 0.2% | 0.0 |
| MeVC23 (R) | 1 | Glu | 3 | 0.2% | 0.0 |
| SLP249 (R) | 2 | Glu | 3 | 0.2% | 0.3 |
| CB0670 (R) | 1 | ACh | 2 | 0.2% | 0.0 |
| LoVP81 (R) | 1 | ACh | 2 | 0.2% | 0.0 |
| PLP174 (R) | 1 | ACh | 2 | 0.2% | 0.0 |
| LPT28 (R) | 1 | ACh | 2 | 0.2% | 0.0 |
| MeVP7 (R) | 1 | ACh | 2 | 0.2% | 0.0 |
| CB3001 (R) | 1 | ACh | 2 | 0.2% | 0.0 |
| MeVPLo2 (R) | 1 | ACh | 2 | 0.2% | 0.0 |
| Lat5 (R) | 1 | unc | 2 | 0.2% | 0.0 |
| MeVPaMe2 (L) | 1 | Glu | 2 | 0.2% | 0.0 |
| MeVPMe4 (L) | 1 | Glu | 2 | 0.2% | 0.0 |
| MeVP38 (R) | 1 | ACh | 2 | 0.2% | 0.0 |
| aMe_TBD1 (R) | 1 | GABA | 2 | 0.2% | 0.0 |
| LoVCLo3 (L) | 1 | OA | 2 | 0.2% | 0.0 |
| Tm20 (R) | 2 | ACh | 2 | 0.2% | 0.0 |
| aMe4 (R) | 2 | ACh | 2 | 0.2% | 0.0 |
| MeVP26 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| aMe17a (R) | 1 | unc | 1 | 0.1% | 0.0 |
| Tm5Y (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| Tm5c (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| TmY10 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| MeLo7 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| SLP322 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| MeVP14 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| WED094 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| MeVP12 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| PLP_TBD1 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| PLP261 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| SMP340 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| LoVP43 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| LoVP71 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| PLP069 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| LoVP72 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| LoVP36 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| SMP200 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| PLP142 (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| MeVP39 (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| CL352 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| LoVP39 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| CL133 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| MeVP62 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| PS272 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| LoVP48 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| LoVP59 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| LT55 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| LoVP64 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| LoVP103 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| MeVP33 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| LT88 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| LoVP90a (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| MeVP29 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| LoVP54 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| MeVC22 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| l-LNv (R) | 1 | unc | 1 | 0.1% | 0.0 |
| MeVPMe3 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| CL357 (R) | 1 | unc | 1 | 0.1% | 0.0 |
| MeVPOL1 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| LoVCLo3 (R) | 1 | OA | 1 | 0.1% | 0.0 |
| DNp27 (R) | 1 | ACh | 1 | 0.1% | 0.0 |